Ulu Sevgi Tatar
Istanbul University, Faculty of Pharmacy, Department of Analytical Chemistry, Istanbul, Turkey.
J AOAC Int. 2006 Sep-Oct;89(5):1263-7.
A sensitive and specific spectrofluorimetry method was developed and validated for the quantification of ephedrine (EP) in pharmaceutical preparations. The method is based on the fluorescent enhancing reaction of EP with 7-chloro-4-nitrobenzofurazan (NBD-C1; derivatization reagent), in borate buffer of pH 9 to yield a yellow, fluorescent product. Under these experimental conditions, the derivatized product of EP had excitation and emission wavelength maxima at 458 and 516 nm, respectively. The linear range of this method was 20-2500 ng/mL. The detection limit was 7.3 ng/mL EP. Intra- and interday precisions of the assay at 3 concentrations within this range were 0.037-1.77%. The low relative standard deviation values indicate good precision, and high recovery values indicate excellent accuracy of the method. The proposed method was applied to the determination of the examined drugs in pharmaceutical formulations, and the results indicate that the method is equally as accurate, precise, and reproducible as the official method.
开发并验证了一种灵敏且特异的荧光分光光度法,用于定量测定药物制剂中的麻黄碱(EP)。该方法基于EP与7-氯-4-硝基苯并呋喃(NBD-C1;衍生化试剂)在pH 9的硼酸盐缓冲液中发生荧光增强反应,生成黄色荧光产物。在这些实验条件下,EP的衍生化产物的激发波长和发射波长最大值分别为458和516 nm。该方法的线性范围为20 - 2500 ng/mL。检测限为7.3 ng/mL EP。在此范围内3个浓度下该测定法的日内和日间精密度为0.037 - 1.77%。低相对标准偏差值表明精密度良好,高回收率值表明该方法具有出色的准确度。所提出的方法应用于药物制剂中被测药物的测定,结果表明该方法与官方方法同样准确、精密且可重现。